Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PhoenixBio Co., Ltd.
No Price
Closing Price XTKS 28.04.2026:
428,00 JPY
28.04.2026 06:30
Current Prices from PhoenixBio Co., Ltd.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
Tokyo
6190.T
JPY
28.04.2026 06:30
428,00 JPY
-3,00 JPY
-0,70 %
Share Float & Liquidity
Free Float26,02 %
Shares Float1,06 M
Shares Outstanding4,07 M
Company Profile for PhoenixBio Co., Ltd. Share
PhoenixBio Co., Ltd. provides contract study services for drug discovery and development primarily in Japan. The company uses PXB-mouse, a chimeric mouse with a humanized liver for use in drug development experiments; and in vitro studies using fresh human hepatocytes taken from PXB-cells. The chimeric mouse model with a humanized liver is used for in vivo studies in gene therapeutics, NASH/NAFLD drug development programs, anti-viral therapeutic tests, DMPK/toxicity studies, and custom transplantations. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.
